TCL Archive Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies May 11, 2012
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
TCL Archive FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting March 19, 1976
